EN | TR
E-ISSN: 3061-9947
Long-Term Oncological Outcomes for Patients Treated with Oncoplastic Breast-conserving Surgery
PDF
Cite
Share
Request
Original Article
VOLUME: 55 ISSUE: 1
P: 16-24
2022

Long-Term Oncological Outcomes for Patients Treated with Oncoplastic Breast-conserving Surgery

Acta Haematol Oncol Turc 2022;55(1):16-24
DOI: 10.5505/aot.2022.67209
Gamze Kızıltan 1
Lütfi Doğan 2
Mehmet Ali Gülçelik 3
Cihangir Özaslan 2
1. Department of General Surgery, University of Health Sciences Dr AY Ankara Oncology Hospital, Ankara, TURKEY
2. Department of Surgical Oncology, University of Health Sciences Dr AY Ankara Oncology Hospital, Ankara, TURKEY
3. Department of Surgical Oncology, University of Health Sciences Gulhane Research and Treatment Hospital, Ankara, TURKEY
4.
No information available.
No information available
Received Date: 2021-06-28T13:27:40
Accepted Date: 2022-03-31T17:36:02
PDF
Cite
Share
Request

Abstract

INTRODUCTION

Oncoplastic breast surgery is a safe and effective surgical technique that improves aesthetic outcomes and broadens the indication for breast-conserving surgery for larger tumors. The purpose of this study was to assess the long-term oncological results of oncoplastic breast-conserving surgery in breast cancer patients.

METHODS

This is a retrospective study of 230 breast cancer patients who underwent volume displacement oncoplastic breast surgery techniques between 2007 and 2014. Most of the similar studies had evaluated only patients with early-stage breast tumors. We did not limit our data due to the tumor stage to analyze all and see if tumor size affects the safety of this technique. We explored patient and tumor characteristics, surgical treatments, surgery-related complications, and pathological outcomes. Moreover, disease-free survival, overall survival, and local recurrence rates of 10 years follow-up were also estimated.

RESULTS

The median follow-up time was 73 months (range 7–149 months). The 10-year disease free survival (DFS) rate was 74.4%, and 10-year overall survival (OS) was 80.0%. The 10-year local recurrence rate was 1.7%. The early complication rate was 22.6%.

DISCUSSION AND CONCLUSION

The oncoplastic breast-conserving surgery is a method that can be applied safely without unfavorable effects on local relapse and survival rates, even for large tumors.